Patents by Inventor Rama K. Mallampalli

Rama K. Mallampalli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BENZATHINE ANALOGS
    Publication number: 20160237040
    Abstract: A compound, or a pharmaceutically acceptable salt or ester thereof, having a structure of: wherein X is a divalent linking moiety; and R1-R10 are each individually H, optionally-substituted alkyl, optionally-substituted alkoxy, optionally-substituted aryl, optionally-substituted cycloalkyl, optionally-substituted heterocyclic, halogen, amino, or hydroxy, provided that at least one of R3 or R8 is an optionally-substituted alkyl, a substituted alkoxy, optionally-substituted aryl, optionally-substituted cycloalkyl, optionally-substituted heterocyclic, or halogen.
    Type: Application
    Filed: April 25, 2016
    Publication date: August 18, 2016
    Applicants: University of Pittsburgh - Of the Commonwealth System of Higher Education, The United States Government as represented by the Department of Veterans Affairs
    Inventors: Beibei Chen, Rama K. Mallampalli
  • Benzathine analogs
    Patent number: 9359284
    Abstract: A compound, or a pharmaceutically acceptable salt or ester thereof, having a structure of: wherein X is a divalent linking moiety; and R1-R10 are each individually H, optionally-substituted alkyl, optionally-substituted alkoxy, optionally-substituted aryl, optionally-substituted cycloalkyl, optionally-substituted heterocyclic, halogen, amino, or hydroxy, provided that at least one of R3 or R8 is an optionally-substituted alkyl, a substituted alkoxy, optionally-substituted aryl, optionally-substituted cycloalkyl, optionally-substituted heterocyclic, or halogen.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: June 7, 2016
    Assignees: University of Pittsburgh—Of the Commonwealth System of Higher Education, The United States of America as represented by the Department of Veterans Affairs
    Inventors: Beibei Chen, Rama K. Mallampalli
  • FBXO3 INHIBITORS
    Publication number: 20150152041
    Abstract: A compound, or a pharmaceutically acceptable salt or ester thereof, having a structure of: wherein X is a divalent linking moiety; and R1-R10 are each individually H, optionally-substituted alkyl, optionally-substituted alkoxy, optionally-substituted aryl, optionally-substituted cycloalkyl, optionally-substituted heterocyclic, halogen, amino, or hydroxy, provided that at least one of R3 or R8 is an optionally-substituted alkyl, a substituted alkoxy, optionally-substituted aryl, optionally-substituted cycloalkyl, optionally-substituted heterocyclic, or halogen.
    Type: Application
    Filed: March 13, 2013
    Publication date: June 4, 2015
    Applicants: University of Pittsburgh - Of the Commonwealth System of Higher Education, The Unite State Government as represented by the Department of Veterans Affairs
    Inventors: Beibei Chen, Rama K. Mallampalli
  • Methods and compositions related to PLUNC surfactant polypeptides
    Patent number: 7951781
    Abstract: Embodiments include compositions and methods for lower the surface tension of a liquid-air interface by contacting such interface with all or part of a PLUNC polypeptide.
    Type: Grant
    Filed: November 2, 2007
    Date of Patent: May 31, 2011
    Assignee: University of Iowa Research Foundation
    Inventors: Paul B. McCray, Jr., Lokesh Gakhar, Rama K. Mallampalli, Subramanian Ramaswamy, Jennifer Bartlett
  • Methods and Compositions Related to PLUNC Surfactant Polypeptides
    Publication number: 20090110756
    Abstract: Embodiments include compositions and methods for lower the surface tension of a liquid-air interface by contacting such interface with all or part of a PLUNC polypeptide.
    Type: Application
    Filed: November 2, 2007
    Publication date: April 30, 2009
    Inventors: Paul B. McCray, JR., Lokesh Gakhar, Rama K. Mallampalli, Subramanian Ramaswamy, Jennifer Bartlett
  • CCT protein expression promoter
    Patent number: 7230091
    Abstract: The present invention provides a noveal isolated and purified nucleic acid molecule having a nucleotide sequence that in nature directs transcription of CTP:phosphocholine cytidylyltrransferase (CCT), i.e., is a novel CCT promoter, and methods of use thereof.
    Type: Grant
    Filed: September 5, 2001
    Date of Patent: June 12, 2007
    Assignee: University of Iowa Research Foundation
    Inventor: Rama K. Mallampalli